Requirements for transplanted skeletal cells to function electrically within ventricular myocardium  by Shaw, Robin M. & Lee, Randall J.
192A ABSTRACTS - Cardiac Function and Heart Failure 
relaxation prior to SQ BNP, n=2). 
Conclusion: Acute SQ BNP reduced cardiac filling pressures and improved lusltropic 
function as evidenced by the changes in the Doppler patterns and the decrease in 
plasma ANP. This investigation supports the conclusion that SQ BNP is an effective 
treatment strategy for this lusltropic hormone and that plasma ANP may serve as a 
serum marker for cardiac filling pressures during the administration of BNP. 
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869-6 Epldemlology of Systolic and Diastolic Dysfunction 
Heart Failure In 3,471 Urban PaUenta 
Akshav K. Khandelwal, John E. McKinnon, Heather J. Shenkman, Vijayamalini Pampati, 
David Nod, Scott Kaatz, Keisha R. Sandberg, Peter A. McCullough, Henry Ford Hospital, 
Detroit, Michigan, University of Missouri-Kansas City School of Medicine, Truman 
Medical Center, Kansas City, Missouri. 
BACKGROUND: We sought to describe congestive heart failure (CHF) in an urban set- 
ring with respect systolic dysfunction (SYS-D) and diastolic dysfunction (DIA-D) in terms 
of age, sex, race, and echo parameters, and survival. 
METHODS: Data were abstracted from the Resource Utilization Among Congestive 
Heart Failure Study, which identified 29,686 CHF patients from a large urban mixed- 
model managed care organization from 1989 to 1999. A target population of 3,471 had 
clinical data taken from automated sources during the first year of diagnosis. We defined 
DIA-D as the presence of CHF with an ejection fraction (EF) of _> 45%, Survival was ana- 
lyzed by Cox regression methods. 
RESULTS: Among the CHF population, 52.2% had DIA-D. A total of 751 men (43.6%) 
and 1,060 women (60.6%), p<0.OOl, 773 whites (54.1%) and 986 blacks (51.2%), p > 
0.05, had DIA-D. Prevalence of DIA-D trended with age, from 46.4% <45 years to 58.7% 
85+ years (p<0.001 for trend). Mean EF was 55.66 vs. 27.96, left ventricular end systolic 
diameter was 3.11 vs. 4.74 cm, and left atdal/aortic outlet ratio was 1.28 vs. 1.38 for DIA- 
D and SYS-D, respectively (p<O.001 for both). Annual age-adjusted mortality was t 1.2% 
and 13.0% for DIA-D and SYS-D, respectively (see figure) (p<0.001). 
CONCLUSIONS: A majority of urban CHF patients including equal proportions of blacks 
and whites have DIA-D and enjoy a slightly better age-adjusfed survival than their coun- 
terparts with SYS-D. 
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1204-141 Slmvastatln Preserves Myocardial Perfuaion and 
Permeability in Experimental Hypercholestarolemia 
Independent of Lipid Lowering 
Piero O. Bonetti, Stephanie H. Wilson, Martin Roddguez-Porcel, David R. Holmes, Jr., 
Lilach O, Lerman, Amir Lerrnan, Division of Cardiovascular Diseases and Division of 
Hypertension, Mayo Clinic, Rochester, Minnesota. 
Background: Experimental Hypercholesterolemia (HC) leads to endothelial dysfunction, 
which is charactedzed by impaired endothelium dependent vasorelaxation and increased 
vascular permeability. Statins have been shown to preserve endothelial function in HC 
not only by cholesterol Iowedng but also by direct lipid-lowering-independent mecha- 
nisms. However, the impact of these effects upon myocardial perfusion (MP) and vascu- 
lar permeability is still unknown. 
Methods: Pigs were randomized to 3 experimental groups: normal diet (N; n=6), high 
cholesterol diet (HC; n=6) and HC diet plus simvastatin (HC+S; n=6) for 12 weeks. Elec- 
tron beam computed tomogrephy studies of the heart were performed before and during 
intravenous infusion of adenosine, and MP and microvascular permeability index (PI) 
were measured in vivo. 
Results: Total and LDL-cholesterol were similarly and significantly increased in the HC 
and HC+S group compared to N. Basal MP was similar in all groups, as was basal PI. 
The changes of MP and PI in response to adenosine are shown in the figure below. 
Conclusion: The current study demonstrates that the impairment of MP and the increase 
in PI in response to cardiac stress associated with experimental HC are prevented by 
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simvastatin therapy in the absence of any lipid-lowering effect. This study suggests a role 
for statins for preservation of myocardial perfusion in pathophysiological states associ- 
ated with coronary endothelial dysfunction. 
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1204-142 Effect of Drug-Induced Hypothyroidism on Cardiac 
Function of Mice Expressing a Troponin T Mutation 
Associated With Familial Hypertrophic Cardlomyopathy 
Biosm C. Knollmann. Todd E. Miller, Fatima DeFreltas, Nell J. Weissman, James D. 
Potter, Georgetown University School of Medicine, Washington, DisL of Columbia, 
University of Miami School of Medicine, Miami, Florida. 
The cardiac phenotype of transgenic mice expressing the FHC-linked Troponin T (TnT- 
179N) mutation is characterized by increased myofilament Ca2+-sensltivity, left-ventricu- 
lar hypercontractility, PR prolongation on ECG, and cardiac dysfunction in response to 
inotropic stimulation. Here we examine the effect of drug-induced hypothyroidism in this 
model. Methods: 179N transgenic mice and non-transgenic Ilttermatas (Non-Tg) were 
fed a diet containing 0.15% 5-propyl-2-tbiouracil (PTU) to induce hypothyroidism, which 
causes an isoform switch from (~- to ~-myosin heavy chain (MHC). This strategy is pre- 
dicted to suppress the transgene expression driven by the c(-MHC promoter. Results: 
After 8 weeks PTU treatment, all mice had clear evidence for hypothyroidism (hair loss, 
bradycardia (275 b/min vs. 400 b/rain, p<.01), PR prolongation on ECG (47rns vs. 40 ms, 
p<.05), prolonged isovolumic relaxation time on Doppler (26ms vs. 16ms, p<.05). ~-MHC 
mRNA was significantly increased, and transgenic TnT-179N mRNA was barely detect- 
able by RT-PCR. Endogenous mouse TnT mRNA and protein was not affected. Trens- 
genic TnT-179N protein was undetectable. Myofilament Ca-sensitivity of PTU-treatad 
179N mice was not significantly different from non-transgenic Iittermatas. PTU treatment 
also abolished all differences in contractile parameters between 179N mice and non- 
transgenic littermates measured by echocardiography, Doppler, and isovolumic heart 
experiments (LV fractional shortening of 179N vs. Non-Tg: Control diet: 42±2% vs. 
31±1%, n= 11, p<0.001; PTU diet: 31±2% vs. 32±2%, n=11, p=0.86). Although PTU 
treatment itself prolonged the PR interval, the PR interval remained significantly longer in 
179N mice, both in surface ECG and isolated heart expedments. Conclusion: PTU treat- 
ment resulted in transcriptional downregulation of transgene expression and reversed 
most, but not all effects of cardiac-targeted transgenic protein expression. 
1204-143 Mesenchymal Stem Cell Transplantation In the 
Repertused or Nonreperfused Myocardial Infarction 
Scar Tissues 
Tae-Jin Youn. Bo-Ra Sohn, Hainan Piao, Jin-Sook Kwon, So-Young Choi, Dong-Woon 
Kim, Young-Gyu Kim, Myeong-Chan Cho, College of Medicine, Chungbuk National 
Universi~ Cheongju, South Korea. 
Background: Mesencbymai stem cells (marrow stromal cells, MSCs) have myogenic 
potentials and transplantation of MSCs is considered to be a novel therapeutic approach 
for post-myocardial infarction (MI) heart failure. We tested whether transplanted MSCs 
could be implanted and subsequently survived in the reperfused or non-reperfused MI 
scar tissues in rats. 
Methods and Results: Female Spregue-Dawley rats were randomly assigned to one of 
three groups: group 1, 45-minute left coronary artery ligation followed by reperfusion 
(early reperfusion with myocardial salvage); group 2, 4-hour left coronary artery ligation 
followed by reperfusion (late reperfusion without myocardial salvage); and group 3, per- 
manent left coronary artery ligation (non-reperfused MI). MSCs from adult rats were cul- 
tured, treated with 5-azacytidine (5-aza, 10 I~mol/L) or not and labeled with 4',6- 
diamidino-2-phenylindole (DAPI) for 80 minutes before transplantation. At 1 week after 
MI, cultured MSCs (lx106 cells), 5-aza-treatad MSCs (lx10 s cells), and medium (control) 
were autologously transplanted into the eady- and lata-reperfused and non-reperfused 
MI scar tissues (n=5, each). At 1 week after transplantation, numerous scattered DAPI- 
labeled cells were detected in early-reperfused infarct tissues irrespective of 5-aza treat- 
ment, However, in late-reperfused and non-reperfused infarct tissues, only scanty DAPI- 
positive cells were identified, 
Conclusion: Both 5-aza untreated and treated MSCs could be transplanted successfully 
and viable until 1 week in early-reperfused infarct tissues, However, in late-reperfused 
and non-repel-fused infarct tissues, transplanted MSCs could not survive, Our results 
implicate that early restoration of blood flow and salvage of myocardium is crucial for the 
fate of transplanted MSCs after MI. 
1204-144 Requirements for Transplanted Skeletal Cells to 
Function Electrically Within Ventricular Myocardium 
Robin M. Shaw. Randall J. Lee, UCSF, San Francisco, California. 
BACKGROUND: Skeletal myocyta transplantation into diseased ventricle is suggested 
as s future therapy for patients with infarcted, non-regenerating myocardium. However 
despite initial clinical success, there is little evidence that implanted skeletal cells can 
communicate lectrically with each other, or with surrounding myocerdium. We assessed 
the electrical requirements for skeletal cells to communicate with each other and with 
ventdcular myocytas. 
METHODS: Theoretical strands were developed composed of sophisticated mathemati- 
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cal models of mammalian ventricular cells (dynamic Luo Rudy formulation) and early 
(myoblast) and late (myofiber) differentiated skeletal cells. The strands were either 
homogenous, or of mixed (half/half) cardiac and skeletal myofiber forms. They were used 
to explore coupling requirements and effects of action potential morphology on ventricu- 
lar-sketstal interaction. 
RESULTS: The action potential duration (APE)) of skeletal cells is short (2.5 ms) and is 
the major limitation of skeletal-to-skeletal and skeletal-to-cardiac excitation. A high 
degree of intercellular coupling was required for skeletal cells to excite their downstream 
neighbors quickly enough, within 2.5 ms, prior to there own repoladzation. The cardiac 
APD is long (178 ms) and there was a long length of time for cardiac cells to charge their 
downstream neighbor, before the charging cell repoladzes. Decreasing intercellular cou- 
pling increased the time necessary to charge adjoining cells. The ratio of intercellular 
coupling reduction to still allow cell-to-cell excitation in homogeneous trands was 45:5:1 
for the ventricular, skeletal myoblast, and skeletal myofiber cell types, respectively. In 
mixed strands, the limiting factor in excitation was any instance that the skeletal cell was 
the source cell. 
CONCLUSION: Skeletal cells need a very high degree of coupling to their neighbors and 
to ventricular myocardium for adequate call-to-cell action potential flow. Gene therapy 
based interventions that prolong the skeletal APD such as introducing a slow inward cal- 
cium current, or use of cells with action potentials longer than 3 ms, would decrease this 
coupling requirement. 
1204-145 Compar i son  of  the  Ef fects  of  L is inopr i l  and a Prolyl 4- 
Hydroxylase Inhibitor (FG041) on Left Ventricular 
Function After Acute Myocardial Infarction 
John I. Nwoau, Maurice Bean, David L Geenen, Jay Bagai, Ajanta De, Beth E. Reed, 
Mehdi Nafissi, Mitchell Brenner, Peter M. Buttrick, University of Illinois at Chicago, 
Chicago, Illinois, Fibrogen INC, South San Francisco, California. 
Background: We have previously shown that proly 4- hydroxylase (P4H) inhibition by 
FG041, which specifically inhibits collagen biosynthesis when given after myocardial inf- 
arction (MI) decreases fibrosis, and improves left ventricular function (LVEF) and sur- 
vival. ACE inhibitors decrease fibrosis and produce similar beneficial effects. It is unclear 
if ACE inhibitors and P4H inhibitors will produce similar and complementary effects on LV 
function post MI. Method: Rats who underwent left coronary artery ligation to produce MI 
were randomized to Lisinopril (Lie, n=13, at 15mg/kg QD) and FG041 (P4H, n=13,at 
50mg/kg BID), Lisinopril and FG041 at same dose (LisP4H, n=10) and to vehicle (con, 
n=13). Echo was performed weekly for 4 weeks then biweekly till week 8 using a 15 mHz 
Linear probe, Results: At randomization, LV function and dimensions were similar in aH 
groups. P4H and Lis produced similar improvement in LVEF compared to control (P<0.05 
weeks 2-6, P =NS week 8). Combination therapy produced a more favorable effect on 
LVEF (see figure P<O.05 weeks 2-8 vs. con) and LV diastolic function (mitral inflow veloc- 
ity 0.97m/s vs. 1.34m/s in con, p=0.028). Conclusion: Our data shows that FG041 and 
Lisinopril produced similar improvement in LVEF while combination therapy produced 
greater improvement in LV systolic and diastolic functions. Thus the two agents have 
comparable and complementary effects on LV function post MI. 
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1205-137 Atlas: Do Gender Differences Affect Outcome Results? 
Mareo M. Schleman. AstraZeneca LP , Clinical Research, Wayne, Pennsylvania. 
Background: The Assessment of Treatment with Lisinopdl (L) and Survival (ATLAS) trial 
found high dose L (32.5-35 mg) reduced combined endpoint of deaths and hospitaliza- 
tions by 12% (p=0.0002) and trended to a reduction in all cause mortality by 8% 
(p=0.128). Women (n=648) comprised 20% of patient poulation. This retrospective anal- 
ysis examined whether gender differences were present in demography, outcome 
results, or tolerabilty. Methods: A retrospective analysis of ATLAS data base was made 
based on gender and high and low dose L. Descriptive statistics were applied and an 
arbitrary cut off of 10% was used to identify differences. Results: Demography; Women 
had more history of hypertension than men (48% vs 19.4%) and men had more history of 
ischemic heart disease than women (67.5% vs 52%). Baseline systolic BP was higher in 
women (123.1 mmHg vs 119.4 mmHg). El:, NYHA class, DBP, and previous ACE inhibi- 
ABSTRACTS- Cardiac Function and Heart Failure 193A 
tor use were similar in both groups. Outcome results; All cause mortality hazard ratio 
(HR) for L (high dose :low dose) was neutral in women(HR=1.054, p=0.677) but trended 
positively in men (HR=0.891, p=0.053). Total mortality on either L dose in men was 1130 
(45%) compared to 253 (39%) in women. HR for mortality plus hospitalizations was 
favorable in both women and men, HR=0.829, p=0.033 in women and HR=0.899, 
p=0.016 in men. Tolerability; High dose L was generally well tolerated in both men and 
women. Drop outs related to an Adverse Event (AE) occurred in 115 women (17.7%) and 
in 439 men (17.4%) with CHF and dyspnea the most frequently observed AEs (17%- 
28%). Increased cough occurred more frequently in women (high dose 14.8%, low dose 
18.1%) than men (high dose 9.5%, low dose 11.9%) and sudden death was noted more 
frequently in men (high dose 15.1%, low dose 16%) than women (high dose11%, low 
dose 10.3%). Conclusion: High dose L was beneficial in men and women in reducing 
mortality plus hospitalizations. A strong trend (p=0.053) towards reducing mortality bene- 
fit in men was observed but not in women. A larger study in women is needed to defini- 
tively evaluate the response in mortality on high dose L. The overall results of ATLAS 
suggest uptitretion of L is of benefit to both men and women. 
1205-1 38 Prognostic Importance of a Wide QRS Complex in 
Asymptomatic Patients with Depressed Left Ventricular 
Function in Predicting Morta l i ty  
Sunny Srivastava, Amin AI-Ahmad, Munther K. Homoud, Mark S. Link, N.A. Mark Estes, 
III, Marvin A. Konstam, Paul J. Wang, Deed N. Salem, New England Medical Center, 
Boston, Massachusetts. 
Background: A wide QRS complex in patients with clinical heart failure is a potent predic- 
tor of death. However, the prognostic value of a wide QRS complex in asymptomatic 
patients with depressed left ventricular function is not known. 
Methods: We performed a retrospective analysis on the 4228 patients enrolled in the 
Studies of Left Ventdcular Dysfunction Prevention Trial. All patients had a left ventricutar 
ejection fraction (LVEF) < 35% (mean 28.3%). The mean follow up was 32+/-15 months. 
QRS duration was noted to be > 120ms in 1186 patients and < 120ms in 2292 patients 
upon enrollment into the trial, A QRS duration > 120ms was evaluated as a predictor of 
all cause mortality univariata analysis with a Log-rank statistic. A Cox regression model 
was constructed for multivariate analysis with covariates that included LVEF, age, medi- 
cation and medical history. 
Results: A QRS duration > 120ms was not associated with an increased risk of death 
(univadate p = 0.3t, multivariate p = 0.46). 
Conclusions: In contrast o patients with clinical heart failure, in patients with asymptom- 
atic left ventricular dysfunction QRS duration does not appear to be a predictor for mor- 
tality. 
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1205-140 impact of South Asian (SA) Ethnicity On Presentation 
and Outcomes Following Hospitalization for Congestive 
Heart Fai lure (CHF) 
Narendra Sinoh, Milan Gupta, Tuhina Biswas, Quak M. Nguyen, Rouge Valley Health 
System-CHC site, Toronto, Ontario, Canada, William Osier Health Centre-Brampton 
campus, Brampton, Ontario, Canada. 
SA develop CAD at a younger age and have larger Ml's compared to European Canadi- 
ans (EU). We hypothesized that SA would therefore also develop CHF at a younger age. 
A retrospective review of 887 consecutive pts admitted between 1997-99 to 2 large com- 
munity hospitals with a primary diagnosis of CHF was performed. 
Results: CAD was the primary etiology of CHF in both groups (49 vs 48%). Pts with car- 
diac enzymes > 2 times normal were excluded. 99 (11%) of pts were SA and 728 (79%) 
were EU based on name analysis. 51% were males. SA were much younger (69.1 vs 
75.1yrs, p=.000017), had more diabetes (57 vs 39% p<,001), were less likely smokers 
(24% vs 41% p<.01 ) had lower body mass index (24.4 vs 26.7kg/m2, p=.003), but similar 
hypercholesterolemia (27 vs 22%), hypertension (62 vs 59%), and family history of CAD 
(10 vs 9%). Prior history of CHF was similar in both groups (57 vs 58%) with the average 
ejection fraction also being similar (40 vs 42%). 
On presentation, HR (98.1vs95.7 bpm p=0.4) and BP (139/82 vs 138/77, p=.02) trended 
higher in SA. Serum sodium was lower (135 vs 137mmol, p=,0002). Initial (150 vs 
135mmol, p=0.1) and discharge creatinine (172 vs 144mmol, p=.014) were higher in SA. 
Most in-hospital complication rates were similar but SA had more ventdcular arrhythmias/ 
cardiac arrest (10 vs 5%, p<.05) and less afib (15 vs 24% p<.05). Unadjusted mortality 
was similar (6 vs 11%, p=ns). Evidence-based drug therapies were used with similar fre- 
quency. Overall 66% received ACEVARB, 84% diuretic, 20% beta blockers, 17% 
spironolactone and 11% statins. 
Conclusion Substantial differences at presentation are seen in SA pts hospitalized for 
